1 Research Way
Princeton, NJ 08540
United States
609 642 6670
https://www.pmvpharma.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 63
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Dr. David H. Mack Ph.D. | Co-Founder, CEO, President & Director | 762,02k | N/A | 1962 |
Dr. Arnold J. Levine Ph.D. | Co-Founder, Director & Member of Scientific Advisory Board | 140k | N/A | 1940 |
Dr. Thomas E. Shenk Ph.D. | Co-Founder & Member of Scientific Advisory Board | N/A | N/A | 1947 |
Mr. Michael Carulli | Chief Financial Officer | N/A | N/A | N/A |
Mr. Robert Ticktin | General Counsel, Head of Operations & Company Secretary | N/A | N/A | 1962 |
Mr. Tim Smith | Senior VP & Head of Corporate Development and Investor Relations | N/A | N/A | N/A |
Ms. Crystal Zuckerman | Vice President of Human Resources | N/A | N/A | N/A |
Dr. Binh Vu Ph.D. | Senior VP of Drug Discovery & CMC | N/A | N/A | N/A |
Dr. Deepika Jalota Pharm.D. | Chief Development Officer | 579,96k | 87,59k | 1977 |
Dr. Marc Fellous M.D. | Senior VP and Head of Clinical Development & Medical Affairs | N/A | N/A | N/A |
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.
PMV Pharmaceuticals, Inc.s ISS Governance QualityScore, Stand 1. April 2024, lautet 7. Die grundlegenden Scores sind Audit: 6, Vorstand: 6, Shareholderrechte: 7, Kompensation: 8.